ArticleCell death discovery2026
Brain metastases exhibit distinct spatial patterns of resident and infiltrating macrophages.
Article in Cell death discovery, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
4 citing papers in PubMed.
- Microenvironment-derived acetylated amino acids promote glioblastoma treatment resistance.Research square · 2026Article
- Tumor-Associated Macrophages Promote Brain Metastasis.bioRxiv : the preprint server for biology · 2026Article
- Engulfment by brain macrophages in a short-lived vertebrate.bioRxiv : the preprint server for biology · 2026Article
- The paracrine effects of tumor cells on endothelial cells and macrophages in brain metastases with different primary sites.Frontiers in immunology · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
Brain metastases (BrM) are a leading cause of morbidity and mortality, arising in multiple brain compartments. BrM colonization and progression are shaped by interactions with distinct tumor-associated macrophage (TAM) subsets, including microglia (MG), monocyte-derived macrophages (MDM), and border-associated macrophages (BAM). While transcriptomes of TAM have been characterized in detail, their spatial distribution, abundance, and compartment-specific composition -particularly in relation to BrM size and the cancer origin-remain poorly defined. Here, we performed a comprehensive spatial analysis of TAM subtypes across brain regions using experimental BrM models of lung and breast cancer, as well as melanoma. We distinguished TAM subsets by both origin and location, employing genetically traceable mouse models. We observed expansion of MG and BAM, as well as MDM infiltration associated with BrM, albeit with distinct compositions. Parenchymal BrM contained both MG and MDM, whereas ventricular and leptomeningeal BrM contained BAM and MDM but lacked MG. TAM abundance varied with BrM size, compartment, and cancer type: MG predominated in early parenchymal lesions, with MDM becoming dominant as tumors grew. Notably, melanoma BrM exhibited markedly reduced MDM infiltration compared with lung and breast cancer BrM. These findings highlight the need to tailor TAM-targeted therapies not only to the primary tumor type but also to the brain compartment affected. A deeper understanding of TAM dynamics across compartments may improve the precision and efficacy of BrM treatments.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.